Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 301–400 of 1,000
Using 3D in vitro cell culture models in anti-cancer drug discovery
Langhans, S. A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1912731 · Cited by 37
Matsusaka, K., Fujiwara, Y., Pan, C., Esumi, S., Saito, Y., Bi, J., Nakamura, Y., Mukunoki, A., Takeo, T., Nakagata, N., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3471 · Cited by 38
Gold Nanobipyramid‐Mediated Apoptotic Camouflage of Adipocytes for Obesity Immunotherapy
Yan, J., Wang, Y., Mu, Z., Han, X., Bi, L., Wang, X., Song, P., Kang, Y., Wang, L., Zhang, X., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207686 · Cited by 35
Zhou, X., Yan, Z., Hou, J., Zhang, L., Chen, Z., Gao, C., Ahmad, N. H., Guo, M., Wang, W., Han, T., et al. (2024) · Oncogene · doi:10.1038/s41388-023-02923-z · Cited by 38
Liu, D., Che, X., & Wu, G. (2024) · Biomarker Research · doi:10.1186/s40364-023-00545-x · Cited by 38
3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
Samadian, H., Jafari, S., Sepand, M. R., Alaei, L., Malvajerd, S. S., Jaymand, M., Ghobadinezhad, F., Jahanshahi, F., Hamblin, M. R., Derakhshankhah, H., et al. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100160 · Cited by 36
Xiao, M., Shi, Y., Jiang, S., Cao, M., Chen, W., Xu, Y. F., Xu, Z., & Wang, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1039378 · Cited by 37
The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
Zolaly, M. A., Mahallawi, W. H., Khawaji, Z. Y., & Alahmadi, M. A. (2023) · Cureus · doi:10.7759/cureus.40742 · Cited by 36
Review of possible mechanisms of radiotherapy resistance in cervical cancer
Zhang, H., Wang, X., Ma, Y., Zhang, Q., Liu, R., Luo, H., & Wang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1164985 · Cited by 38
Machine Learning–Driven SERS Nanoendoscopy and Optophysiology
Chisanga, M., & Masson, J. (2024) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061622-012448 · Cited by 34
Serras, A. S., Faustino, C. M. C., & Pinheiro, L. M. V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081047 · Cited by 35
Sun, K., Zhi, Y., Ren, W., Li, S., Zheng, J., Gao, L., & Zhi, K. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00569-5 · Cited by 36
Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application
Miyashita, M., Shimizu, T., Ashihara, E., & Ukimura, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168910 · Cited by 36
Zhang, Z., Qiu, X., Yan, Y., Liang, Q., Cai, Y., Peng, B., Xu, Z., & Xia, F. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s329031 · Cited by 39
Reyes-Avendaño, I., Reyes-Jiménez, E., González-García, K., Pérez-Figueroa, D. C., Baltiérrez‐Hoyos, R., Tapia-Pastrana, G., Sánchez-Chino, X. M., Villa‐Treviño, S., Arellanes‐Robledo, J., & Vásquez-Garzón, V. R. (2022) · Antioxidants · doi:10.3390/antiox11020358 · Cited by 37
Ghorbaninezhad, F., Asadzadeh, Z., Masoumi, J., Mokhtarzadeh, A., Kazemi, T., Maleki, L. A., Shotorbani, S. S., Shadbad, M. A., Baghbanzadeh, A., Hemmat, N., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120466 · Cited by 39
Dong, S., Li, W., Li, X., Wang, Z., Zhou, C., Shi, H., He, R., Chen, C., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038650 · Cited by 39
Biochemistry of exosomes and their theranostic potential in human diseases
Dwivedi, M., Ghosh, D., Saha, A., Hasan, S., Jindal, D., Yadava, A., Yadava, A., & Dwivedi, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121369 · Cited by 34
Takatsu, F., Suzawa, K., Tomida, S., Thu, Y. M., Sakaguchi, M., Toji, T., Ohki, M., Tsudaka, S., Date, K., Matsuda, N., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02384-7 · Cited by 38
Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Liu, L., Chen, G., Gong, S., Huang, R., & Fan, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1274547 · Cited by 41
Chen, Y., Sun, J., Hu, D., Zhang, J., Xu, Y., Feng, H., Chen, Z., Luo, Y., Lou, Y., & Wu, H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s338394 · Cited by 33
Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
Huang, Y., Fan, H., & Ti, H. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100902 · Cited by 54
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)
Shen, Y., Sun, L., Wang, S., Zheng, X., & Xu, R. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5706 · Cited by 32
Reviewing the role of P2Y receptors in specific gastrointestinal cancers
Dagenais-Bellefeuille, S., Molle, C. M., & Gendron, F. (2019) · Purinergic Signalling · doi:10.1007/s11302-019-09678-x · Cited by 33
Ercolano, G., Cicco, P. D., Rubino, V., Terrazzano, G., Ruggiero, G., Carriero, R., Kunderfranco, P., & Ianaro, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01456 · Cited by 34
He, M. Y., Han, Y., Cai, C., Liu, P., Chen, Y., Shen, H., Xu, X., & Zeng, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16416 · Cited by 34
Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment
Jang, H., Kim, E. H., Chi, S.-G., Kim, S. H., & Yang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810009 · Cited by 34
Dolatkhah, M., Hashemzadeh, N., Barar, J., Adibkia, K., Aghanejad, A., Barzegar-Jalali, M., Omidian, H., & Omidi, Y. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0094 · Cited by 31
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
Lutz, M. S., Klimovich, B., Maurer, S., Heitmann, J. S., Märklin, M., Zekri, L., Jung, G., Salih, H. R., & Hinterleitner, C. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003655 · Cited by 32
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
Singh, S., Barik, D., Arukha, A. P., Prasad, S., Mohapatra, I., Singh, A. R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11102621 · Cited by 34
HIPK2 role in the tumor–host interaction: Impact on fibroblasts transdifferentiation CAF‐like
Garufi, A., Traversi, G., Cirone, M., & D’Orazi, G. (2019) · IUBMB Life · doi:10.1002/iub.2144 · Cited by 32
The Effect of HALP Score on the Prognosis of Gastric Adenocarcinoma
Sargın, Z. G., & Düşünceli, İ. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.09.1154 · Cited by 30
Tumor Microenvironment – Selective Pressures Boosting Cancer Progression
Nunes, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_2 · Cited by 34
Li, Y., Li, Q., Li, D., Gu, J., Qian, D., Qin, X., & Chen, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118638 · Cited by 30
Park, S., Oh, J. H., Park, D. J., Zhang, H., Noh, M., Kim, Y., Kim, Y.-S., Kim, H., Kim, Y., Ha, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620166 · Cited by 31
Taki, S., Matsuoka, K., Nishinaga, Y., Takahashi, K., Yasui, H., Koike, C., Shimizu, M., Sato, M., & Sato, K. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003036 · Cited by 34
Novel design of multifunctional nanozymes based on tumor microenvironment for diagnosis and therapy
Xiaoguang, Z., Xu, N., Zhang, L., Wang, D., & Zhang, P. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114456 · Cited by 30
Tang, Y., Hu, S. C., Li, T., & Qiu, X. (2023) · Gene · doi:10.1016/j.gene.2023.147413 · Cited by 32
Sun, X., Wu, Y., Wang, X., Gao, X., Zhang, S., Sun, Z., Liu, R., & Hu, K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030345 · Cited by 29
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Chen, Q., Li, Y., Hu, J., Xu, Z., Wang, S., Cai, N., He, M., Xiao, Y., Ding, Y., Sun, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202406328 · Cited by 36
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
Sharma, R., Yadav, J., Bhat, S. A., Musayev, A., Myrzagulova, S., Sharma, D., Padha, N., Saini, M., Tuli, H. S., & Singh, T. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04680-w · Cited by 36
Photocontrolled Release of the Anticancer Drug Chlorambucil with Caged Harmonic Nanoparticles
Vuilleumier, J., Gaulier, G., Matos, R. D., Mugnier, Y., Campargue, G., Wolf, J., Bonacina, L., & Gerber‐Lemaire, S. (2019) · Helvetica Chimica Acta · doi:10.1002/hlca.201900251 · Cited by 32
Chen, H., Zhang, W., Zhang, L., Yang, P., Li, F., Yang, Z., Wang, J., Pang, M., Hong, Y., Yan, C., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-020-00973-8 · Cited by 32
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Muñoz, R., Girotti, A., Hileeto, D., & Arias, F. J. (2021) · Cancers · doi:10.3390/cancers13215414 · Cited by 34
Iqbal, S., & Zhao, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121289 · Cited by 30
Yu, C.-T., Chen, T., Lu, S., Hu, W., Zhang, Q., Tan, J., Sun, D., Li, L., Sun, X., Xu, C., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s344861 · Cited by 29
The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer
Yu, I., Wu, R., Tokumaru, Y., Terracina, K. P., & Takabe, K. (2022) · Cancers · doi:10.3390/cancers14225685 · Cited by 34
Understanding virus–host interactions in tissues
Speranza, E. E. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01434-7 · Cited by 32
Luo, K., Qian, Z., Jiang, Y., Lv, D., Zhu, K., Shao, J., Hu, Y. C., Lv, C., Huang, Q., Gao, Y., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107078 · Cited by 31
Högström, J., Cruz, K. A., Selfors, L. M., Ward, M. N., Mehta, T. S., Kanarek, N., Philips, J., Dialani, V. M., Wulf, G. M., Collins, L. C., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105021 · Cited by 31
The research progress on radiation resistance of cervical cancer
Liang, M., Sheng, L., Ke, Y., & Wu, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1380448 · Cited by 35
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
Jahandar-Lashaki, S., Farajnia, S., Faraji-Barhagh, A., Hosseini, Z., Bakhtiyari, N., & Rahbarnia, L. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01195-6 · Cited by 34
Malherbe, K. K. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.01.014 · Cited by 29
Magalhães, M., Manadas, B. J., Efferth, T., & Cabral, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105638 · Cited by 30
CXCL3 Signaling in the Tumor Microenvironment
Reyes, N., Figueroa, S., Tiwari, R. K., & Geliebter, J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_2 · Cited by 34
Sun, C., Ma, S., Chen, Y., Kim, N. H., Kailas, S., Wang, Y., Gu, W., Chen, Y., Tuason, J. P. W., Bhan, C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.843880 · Cited by 34
Critical clinical gaps in cancer precision nanomedicine development
Gan, W. W., Chan, L. W., Li, W., & Wong, T. W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.055 · Cited by 29
Liu, J., Yu, L., Tian, G., & Yang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.899156 · Cited by 28
Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives
Liu, L., & Chen, J. (2022) · Medical Review · doi:10.1515/mr-2022-0033 · Cited by 29
Exosomes and cancer immunotherapy: A review of recent cancer research
Cao, Y., Xu, P., Shen, Y., Wu, W., Chen, M., Wang, F., Zhu, Y., Yan, F., Gu, W., & Lin, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1118101 · Cited by 28
Frontier Review of the Molecular Mechanisms and Current Approaches of Stem Cell-Derived Exosomes
Chen, L.-Y., Kao, T., Chen, C.-C., Niaz, N., Lee, H., Chen, Y., Kuo, C., & Shen, Y. (2023) · Cells · doi:10.3390/cells12071018 · Cited by 31
Abdolahinia, E. D., & Han, X. (2023) · Cancers · doi:10.3390/cancers15174266 · Cited by 30
Valera, P. S., Plou, J., Garcı́a, I., Astobiza, I., Viera, C., Aransay, A. M., Martín, J., Sasselli, I. R., Carracedo, A., & Liz‐Marzán, L. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311674120 · Cited by 28
Afkhami, H., Mahmoudvand, G., Fakouri, A., Shadab, A., Mahjoor, M., & Komeili Movahhed, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1255697 · Cited by 27
Galectins in the Tumor Microenvironment: Focus on Galectin-1
Martínez‐Bosch, N., & Navarro, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_2 · Cited by 31
Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score
Shou, Y., Yang, L., Yang, Y., Zhu, X., Li, F., & Xu, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.570530 · Cited by 33
Stimuli-Responsive Aliphatic Polycarbonate Nanocarriers for Tumor-Targeted Drug Delivery
Domiński, A., Konieczny, T., Duale, K., Krawczyk, M., Pastuch-Gawołek, G., & Kurcok, P. (2020) · Polymers · doi:10.3390/polym12122890 · Cited by 33
Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review)
Salihi, A. B., Al-Naqshabandi, M. A., Khudhur, Z. O., Housein, Z., Hama, H. A., Abdullah, R. M., Hussen, B. M., & Alkasalias, T. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12749 · Cited by 27
The Kv10.1 Channel: A Promising Target in Cancer
Luis, E., Anaya‐Hernández, A., León-Sánchez, P., & Durán-Pastén, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158458 · Cited by 29
Flavonoid-based nanomedicines to target tumor microenvironment
Talib, W. H., Abuawad, A., Thiab, S. H., Alshweiat, A., & Mahmod, A. I. (2022) · OpenNano · doi:10.1016/j.onano.2022.100081 · Cited by 30
Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis
Mukherjee, S., Nag, S., Mukerjee, N., Maitra, S., Muthusamy, R., Fuloria, N. K., Fuloria, S., Adhikari, M. D., Anand, K., Thorat, N. D., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c02837 · Cited by 28
Wu, H., Ma, S.-J., Xiang, M., & Tong, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.076 · Cited by 28
Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond
Pontes, B., & Mendes, F. A. (2023) · Diseases · doi:10.3390/diseases11020086 · Cited by 31
Tang, Y., Feng, X., Lü, Q., Cui, C., Yu, M., Wen, Z., Luan, Y., Dong, L., Hu, Z., Zhang, R., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.12.002 · Cited by 29
Cuproptosis in cancers: Function and implications from bench to bedside
Huang, X.-Y., Shen, J.-Y., Huang, K., Wang, L., Sethi, G., & Ma, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116874 · Cited by 32
Cai, W., Sun, T., Qiu, C., Sheng, H., Chen, R., Xie, C., Kou, L., & Yao, Q. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02925-3 · Cited by 30
Peptide-targeted nanoparticles for tumor therapy
Sidorenko, V., Tobi, A., Sugahara, K. N., & Teesalu, T. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114195 · Cited by 28
Hassan, G., Afify, S. M., Nair, N., Kumon, K., Osman, A., Du, J., Mansour, H. M., Quora, H. A. A., Nawara, H. M., Satoh, A., et al. (2019) · Cancers · doi:10.3390/cancers12010082 · Cited by 27
Santana-Krímskaya, S. E., Franco-Molina, M. Á., Zárate-Triviño, D. G., Prado-García, H., Zapata‐Benavides, P., Torres-del-Muro, F., & Rodríguez-Padilla, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110062 · Cited by 31
Zhang, L.-Y., Zhang, J., Yang, X. F., Cai, M., Zhang, C.-W., & Hu, Z. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666201019111524 · Cited by 30
Addressing Resistance to Immune Checkpoint Inhibitor Therapy: An Urgent Unmet Need
Hu‐Lieskovan, S., Malouf, G. G., Jacobs, I. A., Chou, J., Liu, L., & Johnson, M. L. (2021) · Future Oncology · doi:10.2217/fon-2020-0967 · Cited by 32
TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways
Chen, J., Huang, L., Jin, Q., & Xiang, D. (2021) · Aging · doi:10.18632/aging.203003 · Cited by 27
Huo, J., Wu, L., & Zang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.635324 · Cited by 28
Yang, R., Pei, T., Huang, R., Xiao, Y., Yan, J., Zhu, J., Zheng, C., Xiao, W., & Huang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.774440 · Cited by 32
Jia, Y., Guo, B., Zhang, W., Wang, F., Zhang, Y., Zhang, Q., & Li, E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1110207 · Cited by 28
Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery
Razia, I. T., Kanwal, A., Riaz, H. F., Malik, A., Ahsan, M., Khan, M. S., Raza, A., Sabir, S., Sajid, Z., Khan, M. F., et al. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266258467231107102643 · Cited by 30
Constructing a new prognostic signature of gastric cancer based on multiple data sets
Zhou, L., Lü, H., Zeng, F., Zhou, Q., Li, S., Wu, Y., Yuan, Y., & Xin, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.1940030 · Cited by 26
He, Q., Jiang, H., Zhang, X., & Qin, S. (2020) · Medicine · doi:10.1097/md.0000000000021287 · Cited by 25
Chen, B., Chen, W., Jin, J., Wang, X., Cao, Y., & He, Y. (2019) · Disease Markers · doi:10.1155/2019/8901649 · Cited by 26
Musa, M., & Ali, A. (2020) · Future Oncology · doi:10.2217/fon-2020-0384 · Cited by 28
Li, P., Cao, J., Li, J., Yao, Z., Han, D., Ying, L., Wang, Z., & Tian, J. (2020) · Cancer Medicine · doi:10.1002/cam4.3372 · Cited by 29
Role and dynamics of vacuolar pH during cell-in-cell mediated death
Su, Y. P., Ren, H., Tang, M., Zheng, Y. Y., Zhang, B., Wang, C., Hou, X., Niu, Z., Wang, Z., Gao, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03396-2 · Cited by 28
Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment
Cao, L., Li, W., Yang, X., Zhang, W., Li, M., Zhang, H., Qin, C., Chen, X., & Gao, R. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00354-0 · Cited by 28
Buhrmann, C., Kunnumakkara, A. B., Kumar, A., Samec, M., Kubatka, P., Aggarwal, B. B., & Shakibaei, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650603 · Cited by 27
Hammoud, M. K., Dietze, R., Pesek, J., Finkernagel, F., Unger, A., Bieringer, T., Nist, A., Stiewe, T., Bhagwat, A. M., Nockher, W. A., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13221 · Cited by 27
Wang, Y., Wang, S., Chen, A., Wang, R., Li, L., & Fang, X. (2022) · The Analyst · doi:10.1039/d2an01268e · Cited by 25
Inducing vascular normalization: A promising strategy for immunotherapy
Luo, X., Zou, W., Wei, Z., Yu, S., Zhao, Y., Wu, Y., Wang, A., & Lu, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109167 · Cited by 26
Terracciano, M., Fontana, F., Falanga, A. P., D’Errico, S., Torrieri, G., Greco, F., Tramontano, C., Rea, I., Piccialli, G., Stefano, L. D., et al. (2022) · Small · doi:10.1002/smll.202204732 · Cited by 26
Nano-Clays for Cancer Therapy: State-of-the Art and Future Perspectives
Persano, F., & Leporatti, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101736 · Cited by 27
Performance and Prospects of [68Ga]Ga-FAPI PET/CT Scans in Lung Cancer
Borgonje, P. E., Andrews, L. M., Herder, G. J. M., & de Klerk, J. M. H. (2022) · Cancers · doi:10.3390/cancers14225566 · Cited by 25
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.